- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有275家主力机构披露2025-06-30报告期持股数据，持仓量总计2.84亿股，占流通A股68.05%
- 波段诊断：
-
技术面诊股
诊断结果：5.1技术面打败了23%的股票
技术面评分前10的股票
近期的平均成本为62.00元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为62.00元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"62.00","date":1758097000,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2025.09.18","stock":"0.78","trade":"-0.61","ind":"-1.06"},{"date":"2025.09.17","stock":"-0.08","trade":"-0.67","ind":"1.16"},{"date":"2025.09.16","stock":"-2.99","trade":"-0.09","ind":"0.45"},{"date":"2025.09.15","stock":"-0.22","trade":"-0.14","ind":"0.63"},{"date":"2025.09.12","stock":"1.83","trade":"0.60","ind":"-0.43"},{"date":"2025.09.11","stock":"-0.31","trade":"0.29","ind":"3.36"},{"date":"2025.09.10","stock":"-10.41","trade":"-0.63","ind":"0.38"},{"date":"2025.09.09","stock":"3.25","trade":"-1.92","ind":"-1.23"},{"date":"2025.09.08","stock":"-0.45","trade":"0.35","ind":"0.61"},{"date":"2025.09.05","stock":"-0.85","trade":"1.70","ind":"3.89"},{"date":"2025.09.04","stock":"-7.58","trade":"-1.03","ind":"-2.83"},{"date":"2025.09.03","stock":"1.29","trade":"-0.44","ind":"-0.65"},{"date":"2025.09.02","stock":"-2.40","trade":"-1.31","ind":"-2.14"},{"date":"2025.09.01","stock":"10.91","trade":"2.44","ind":"1.05"},{"date":"2025.08.29","stock":"0.39","trade":"0.69","ind":"0.99"},{"date":"2025.08.28","stock":"1.82","trade":"-0.58","ind":"2.25"},{"date":"2025.08.27","stock":"-2.45","trade":"-3.21","ind":"-1.43"},{"date":"2025.08.26","stock":"-4.22","trade":"-1.06","ind":"0.26"},{"date":"2025.08.25","stock":"4.76","trade":"1.51","ind":"2.26"},{"date":"2025.08.22","stock":"-4.83","trade":"-0.05","ind":"2.07"},{"date":"2025.08.21","stock":"-0.47","trade":"-0.62","ind":"-0.06"}]
一品红,深证成指,化学制药指数
压力支撑
该股压力位为61.63元，支撑位为59.14元。
[{"text":"\u538b\u529b\u4f4d","value":"61.63","date":1758124800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"59.14","date":1758124800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.9资金面打败了84%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：09月18日 20:30
| 机构今日流向(万元) | -1304.03 | 机构5日流向(万元) | -7804.54 |
| 机构10日流向(万元) | -12869.03 | 机构20日流向(万元) | -28658.65 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加4166.12万股，其中基金净减仓10家，主力净增仓190家，请投资者中长期谨慎为宜。
截止2025-06-30，共275家主力机构（基金270家，一般法人5家），持仓量总计28424.24万股，占流通A股68.05%
其中，基金持仓与2024-12-31相比：
增仓：12家 ，增持 554.12万股
减仓：22家 ，减持 130.01万股
新出现在主力名单中：233家 ，持有5568.04万股
从主力名单中消失：43家 ，原持有1701.76万股
其中，基金持仓与2024-12-31相比：
增仓：12家 ，增持 554.12万股
减仓：22家 ，减持 130.01万股
新出现在主力名单中：233家 ，持有5568.04万股
从主力名单中消失：43家 ，原持有1701.76万股
消息面诊股
诊断结果：5.7消息面打败了37%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 一品红：9月17日获融资买入2924.29万元
2025-09-18 - 一品红：9月16日获融资买入2208.46万元
2025-09-17 - 一品红：公司合作方Arthrosi是一家致力于代谢
2025-09-16 - 一品红：9月15日获融资买入5268.58万元
2025-09-16 - 一品红：AR882为具全球竞争力的新一代高效选择性
2025-09-16 - 一品红：全资子公司获盐酸克林霉素棕榈酸酯颗粒注册证
2025-09-15 - 一品红：9月12日获融资买入4562.40万元，占
2025-09-15 - 一品红：9月11日获融资买入7724.59万元
2025-09-12 - 广州生物医药强势崛起，打造产业新高地
2025-09-11 - 一品红：9月10日获融资买入8236.55万元
2025-09-11
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-22 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-22 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-22 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-21 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-06-16 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-17 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-25 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-01-23 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2024-12-26 |
| 一般消息 | 重大事项 | 关联交易 | 2024-10-17 |
| 一般消息 | 重大事项 | 关联交易 | 2024-09-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：2.5行业面打败了18%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.09.18","price":"-1.06","value":"-0.61"},{"date":"2025.09.17","price":"1.16","value":"-0.67"},{"date":"2025.09.16","price":"0.45","value":"-0.09"},{"date":"2025.09.15","price":"0.63","value":"-0.14"},{"date":"2025.09.12","price":"-0.43","value":"0.60"},{"date":"2025.09.11","price":"3.36","value":"0.29"},{"date":"2025.09.10","price":"0.38","value":"-0.63"},{"date":"2025.09.09","price":"-1.23","value":"-1.92"},{"date":"2025.09.08","price":"0.61","value":"0.35"},{"date":"2025.09.05","price":"3.89","value":"1.70"},{"date":"2025.09.04","price":"-2.83","value":"-1.03"},{"date":"2025.09.03","price":"-0.65","value":"-0.44"},{"date":"2025.09.02","price":"-2.14","value":"-1.31"},{"date":"2025.09.01","price":"1.05","value":"2.44"},{"date":"2025.08.29","price":"0.99","value":"0.69"},{"date":"2025.08.28","price":"2.25","value":"-0.58"},{"date":"2025.08.27","price":"-1.43","value":"-3.21"},{"date":"2025.08.26","price":"0.26","value":"-1.06"},{"date":"2025.08.25","price":"2.26","value":"1.51"},{"date":"2025.08.22","price":"2.07","value":"-0.05"},{"date":"2025.08.21","price":"-0.06","value":"-0.62"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 广济药业 | 35.74% | -3.04% | 6.0分 |
| 2 | 百济神州 | 29.48% | 3.20% | 5.4分 |
| 3 | 向日葵 | 25.57% | 7.59% | 5.5分 |
| 4 | 艾力斯 | 20.25% | -6.51% | 5.3分 |
| 5 | 海辰药业 | 19.03% | -8.86% | 4.4分 |
| 6 | 百利天恒 | 16.93% | 9.19% | 5.3分 |
| 8 | 恩华药业 | 14.14% | 8.60% | 5.9分 |
| 10 | 复星医药 | 13.05% | 0.99% | 5.7分 |
| 12 | 恒瑞医药 | 11.10% | 4.10% | 6.5分 |
| 14 | 金城医药 | 9.05% | -4.65% | 5.3分 |
| 16 | 贝达药业 | 7.52% | -1.57% | 5.0分 |
| 18 | ST天圣 | 6.30% | 9.41% | 4.9分 |
| 20 | 兴齐眼药 | 6.12% | -0.91% | 5.5分 |
| 22 | 汇宇制药 | 6.02% | 12.22% | 6.3分 |
| 24 | 人福医药 | 5.15% | -0.91% | 5.6分 |
| 26 | 同和药业 | 3.63% | -2.85% | 5.3分 |
| 28 | 京新药业 | 3.53% | 4.66% | 5.7分 |
| 30 | 多瑞医药 | 3.08% | -1.53% | 5.9分 |
| 32 | 司太立 | 2.50% | 0.25% | 5.8分 |
| 34 | 吉贝尔 | 1.56% | 1.64% | 5.2分 |
| 36 | 健康元 | 0.62% | -0.38% | 4.9分 |
| 38 | 小方制药 | 0.11% | 2.27% | 6.1分 |
| 40 | - | 0.00% | -0.29% | 分 |
| 42 | 新和成 | -0.54% | -2.28% | 5.9分 |
| 44 | - | -1.32% | 0.27% | 分 |
| 46 | 国药现代 | -1.51% | -0.36% | 5.7分 |
| 48 | 鲁抗医药 | -1.94% | 2.64% | 6.1分 |
| 50 | 常山药业 | -2.51% | -4.84% | 4.9分 |
| 52 | 纳微科技 | -3.56% | -2.43% | 6.2分 |
| 54 | 康芝药业 | -3.97% | -1.31% | 5.5分 |
| 56 | 本立科技 | -4.06% | -4.69% | 5.2分 |
| 58 | 誉衡药业 | -4.19% | 0.00% | 5.6分 |
| 60 | 北大医药 | -4.21% | -3.30% | 5.2分 |
| 62 | 亨迪药业 | -4.70% | -3.44% | 5.2分 |
| 64 | 健友股份 | -5.10% | -1.61% | 5.2分 |
| 66 | 共同药业 | -5.13% | -0.72% | 5.7分 |
| 68 | 神奇制药 | -5.25% | -1.04% | 5.7分 |
| 70 | 诚意药业 | -5.70% | -2.93% | 5.3分 |
| 72 | 赛分科技 | -5.74% | 0.72% | 5.6分 |
| 74 | 润都股份 | -5.86% | -0.14% | 5.2分 |
| 76 | 海普瑞 | -6.02% | -2.57% | 5.9分 |
| 78 | 汉商集团 | -6.30% | -3.88% | 5.3分 |
| 80 | 华润双鹤 | -6.42% | -1.34% | 5.4分 |
| 82 | 奥翔药业 | -6.53% | -2.34% | 5.6分 |
| 84 | 华东医药 | -6.64% | -0.19% | 6.0分 |
| 86 | 丰原药业 | -6.86% | -2.49% | 5.2分 |
| 88 | 海森药业 | -6.90% | -2.02% | 5.1分 |
| 90 | 东亚药业 | -7.15% | -2.49% | 5.2分 |
| 92 | 川宁生物 | -7.28% | 0.26% | 4.9分 |
| 94 | 尔康制药 | -7.46% | -1.85% | 5.4分 |
| 96 | 津药药业 | -7.63% | -0.47% | 5.6分 |
| 98 | 富士莱 | -7.82% | -2.42% | 4.9分 |
| 100 | *ST三圣 | -8.03% | -6.53% | 3.6分 |
| 102 | 拓新药业 | -8.12% | -3.49% | 4.3分 |
| 104 | 西点药业 | -8.40% | -3.55% | 5.2分 |
| 106 | 哈药股份 | -8.46% | -0.81% | 5.4分 |
| 108 | 力生制药 | -8.48% | -2.38% | 5.1分 |
| 110 | 莱美药业 | -8.87% | -0.22% | 5.0分 |
| 112 | 华北制药 | -9.09% | -1.96% | 4.9分 |
| 114 | 仟源医药 | -9.20% | 1.20% | 5.8分 |
| 116 | 双鹭药业 | -9.47% | -2.90% | 5.0分 |
| 118 | 金石亚药 | -9.97% | -2.69% | 4.9分 |
| 120 | 易明医药 | -10.32% | 4.47% | 5.8分 |
| 122 | 溢多利 | -10.61% | -3.05% | 4.2分 |
| 124 | 海创药业 | -10.78% | -1.49% | 5.3分 |
| 126 | 首药控股 | -11.05% | 2.10% | 4.7分 |
| 128 | 圣诺生物 | -11.30% | -6.13% | 5.3分 |
| 130 | 亚太药业 | -12.02% | -2.12% | 4.8分 |
| 132 | 一品红 | -12.84% | -0.75% | 5.0分 |
| 134 | 前沿生物 | -13.23% | 2.91% | 5.0分 |
| 136 | 迪哲医药 | -13.61% | -3.37% | 5.4分 |
| 138 | 南新制药 | -14.49% | -3.00% | 4.4分 |
| 140 | 益方生物 | -16.80% | -2.56% | 4.8分 |
| 142 | 广生堂 | -18.03% | -2.32% | 4.6分 |
| 144 | 上海谊众 | -19.73% | 1.70% | 5.1分 |
| 146 | 昂利康 | -21.85% | -2.86% | 5.1分 |
| 148 | - | -23.69% | 0.00% | 分 |
| 150 | 舒泰神 | -30.98% | -6.98% | 4.8分 |
| 152 | 河化股份 | - | -6.94% | 6.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 129/226 ， 55/226。
[{"date":"2025-06-30","value":"-3.98","vol":"1.40"},{"date":"2025-03-31","value":"2.97","vol":"-0.17"},{"date":"2024-12-31","value":"-24.54","vol":"19.77"},{"date":"2024-09-30","value":"-10.48","vol":"4.61"},{"date":"2024-06-30","value":"1.86","vol":"3.55"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-3.98 | 2.97 | -24.54 | -10.48 | 1.86 |
| 行业(%) | 1.40 | -0.17 | 19.77 | 4.61 | 3.55 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"58.28","vol":"49.76"},{"date":"2025-03-31","value":"61.05","vol":"49.23"},{"date":"2024-12-31","value":"61.35","vol":"51.11"},{"date":"2024-09-30","value":"66.53","vol":"50.51"},{"date":"2024-06-30","value":"72.27","vol":"50.85"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
58.28 | 61.05 | 61.35 | 66.53 | 72.27 |
| 行业(%) | 49.76 | 49.23 | 51.11 | 50.51 | 50.85 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 143/226 ， 138/226。
[{"date":"2025-06-30","value":"-36.02","vol":"79.06"},{"date":"2025-03-31","value":"-39.48","vol":"-0.84"},{"date":"2024-12-31","value":"-42.07","vol":"17.88"},{"date":"2024-09-30","value":"-32.98","vol":"45.69"},{"date":"2024-06-30","value":"-27.90","vol":"710.38"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-36.02 | -39.48 | -42.07 | -32.98 | -27.90 |
| 行业(%) | 79.06 | -0.84 | 17.88 | 45.69 | 710.38 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-258.30","vol":"56.66"},{"date":"2025-03-31","value":"-43.70","vol":"-21.21"},{"date":"2024-12-31","value":"-392.52","vol":"-21.14"},{"date":"2024-09-30","value":"-187.44","vol":"-32.33"},{"date":"2024-06-30","value":"-77.33","vol":"8.14"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-258.30 | -43.70 | -392.52 | -187.44 | -77.33 |
| 行业(%) | 56.66 | -21.21 | -21.14 | -32.33 | 8.14 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 116/226 ， 95/226。
[{"date":"2025-06-30","value":"0.12","vol":"0.21"},{"date":"2025-03-31","value":"0.08","vol":"0.10"},{"date":"2024-12-31","value":"0.33","vol":"0.43"},{"date":"2024-09-30","value":"0.28","vol":"0.33"},{"date":"2024-06-30","value":"0.20","vol":"0.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.12 | 0.08 | 0.33 | 0.28 | 0.20 |
| 行业(次) | 0.21 | 0.10 | 0.43 | 0.33 | 0.23 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.83","vol":"1.32"},{"date":"2025-03-31","value":"0.53","vol":"0.67"},{"date":"2024-12-31","value":"1.77","vol":"3.24"},{"date":"2024-09-30","value":"1.35","vol":"2.18"},{"date":"2024-06-30","value":"0.72","vol":"1.51"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.83 | 0.53 | 1.77 | 1.35 | 0.72 |
| 行业(次) | 1.32 | 0.67 | 3.24 | 2.18 | 1.51 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 136/226 ， 34/226。
[{"date":"2025-06-30","value":"-27.06","vol":"2.81"},{"date":"2025-03-31","value":"10.17","vol":"-28.76"},{"date":"2024-12-31","value":"-160.39","vol":"-371.46"},{"date":"2024-09-30","value":"-122.87","vol":"-9.87"},{"date":"2024-06-30","value":"46.60","vol":"-253.98"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -27.06 | 10.17 | -160.39 | -122.87 | 46.60 |
| 行业 | 2.81 | -28.76 | -371.46 | -9.87 | -253.98 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.46","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.40","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.76","vol":"2.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.46 | - | 1.40 | - | 1.76 |
| 行业 | 1.73 | 0.00 | 1.99 | 0.00 | 2.19 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 44/226 ， 26/226。
[{"date":"2025-06-30","value":"1.33","vol":"3.66"},{"date":"2025-03-31","value":"1.13","vol":"3.59"},{"date":"2024-12-31","value":"0.73","vol":"3.32"},{"date":"2024-09-30","value":"1.05","vol":"3.66"},{"date":"2024-06-30","value":"0.92","vol":"3.59"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.33 | 1.13 | 0.73 | 1.05 | 0.92 |
| 行业 | 3.66 | 3.59 | 3.32 | 3.66 | 3.59 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.77","vol":"2.88"},{"date":"2025-03-31","value":"0.71","vol":"2.81"},{"date":"2024-12-31","value":"0.48","vol":"2.63"},{"date":"2024-09-30","value":"0.73","vol":"2.92"},{"date":"2024-06-30","value":"0.48","vol":"2.88"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.77 | 0.71 | 0.48 | 0.73 | 0.48 |
| 行业 | 2.88 | 2.81 | 2.63 | 2.92 | 2.88 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 52/226 ， 10/226。
[{"date":"2025-06-30","value":"62.53","vol":"33.92"},{"date":"2025-03-31","value":"62.08","vol":"34.04"},{"date":"2024-12-31","value":"56.04","vol":"34.34"},{"date":"2024-09-30","value":"51.11","vol":"33.02"},{"date":"2024-06-30","value":"43.69","vol":"33.19"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
62.53 | 62.08 | 56.04 | 51.11 | 43.69 |
| 行业(%) | 33.92 | 34.04 | 34.34 | 33.02 | 33.19 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.72","vol":"0.89"},{"date":"2025-03-31","value":"1.68","vol":"1.46"},{"date":"2024-12-31","value":"1.31","vol":"0.84"},{"date":"2024-09-30","value":"1.07","vol":"0.73"},{"date":"2024-06-30","value":"0.79","vol":"0.71"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.72 | 1.68 | 1.31 | 1.07 | 0.79 |
| 行业(%) | 0.89 | 1.46 | 0.84 | 0.73 | 0.71 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.07","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.91","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.85","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-5.40","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.98","blueLineValue":"0.44","type":"YC"}]